The post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study publishedThe post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study published

Insufficient Sleep Is A Growing Crisis

Melatonin is one of the most widely used sleep supplements.

getty

A study published in 2018 in Healthcare found that in a study of nearly 20,000 individuals, it was reported that almost 27.3% individuals reported they had some type of sleep disorder. Another more recent study indicates that nearly 33% of adults reported insufficient sleep and short-sleep cycles. With growing economies, increasing labor needs and rising wage challenges, insufficient sleep has grown to become a worldwide phenomenon. In fact, many experts attribute these growing trends to increasing stress levels as a part of a viscious cycle: “It is believed that the relationship between stress and sleep is bidirectional—that is, stress can disrupt sleep and sleep loss can increase subsequent stress level.”

Research has also overwhelmingly indicated that lack of sleep can lead to numerous health detriments, including chronic disease, mental health deterioration and even behavioral disorders.

People are increasingly realizing this problem; with increasingly busy lives, more screen time and poorer sleep hygiene, individuals are increasingly relying on supplements, such as melatonin, to help them sleep more.

A new study published by the American Heart Association late last year found an association between long-term melatonin use and heart failure. Specifically, the study reviewed records of over 130,000 adults who used melatonin for needs related to insomnia or sleep disturbances and found a higher likelihood of being diagnosed with heart failure leading to hospitalization. Though not necessarily a finding of causality, the study calls for more research and awareness into the common and routine use of melatonin by millions of individuals daily.

Melatonin is a hormone that is naturally produced by the body to help regulate the sleep-wake cycle; typically, its levels increase during darkness and decrease during daylight, mirroring natural human circadian rhythms. The hormone binds to MT1 and MT2 receptors, triggering a variety of downstream physiological processes to induce fatigue, sleepiness and a generalized “tone of rest.”

For years, synthetic preparations of melatonin have been available for purchase by consumers over-the-counter and commonly marketed as a sleeping aid or solution for circiadian disturbances. However, as the substance is considered a supplement and not a medicine, formulations by manufacturers often bypass strict regulatory controls. In fact, in Europe and countries in Asia, melatonin cannot be acquired without a doctor’s prescription due to the significant impacts it can have with long-term use.

Another study published last year in the World Journal of Pediatrics found that the long-term effects of melatonin on children are simply unknown, despite skyrocketing use in pediatric populations globally. The study also cites that there is no clear efficacy or safety data which can strongly point towards downstream physiologic and pathologic impacts. Despite a lack of clear data on the safety and prognostic findings, melatonin use in young children is common, underscoring the need for more research in age-specific cohorts. Per a recent literature review, it was found that “the use of melatonin as a sleep aid for children younger than age 6 has increased around the world over the last 20 years, and especially over the last decade. In countries where melatonin requires a prescription, these prescriptions have increased by as much as 500% in some areas. Moreover, the studies showed increases in extended use of melatonin, with young children getting refills two and three years after the initial prescription.”

Fortunately, there has been more awareness and education over the past decade regarding non-medication related interventions to improve sleep for both pediatric and adult populations. Wellness clinics are increasingly emerging across the globe to help institute better sleep routines and methods for patients. New wearbles and activity trackers are including sleep monitoring into their hardware. Even new phone applications have been developed solely for the endeavor of helping users sleep. There is also more research and conversation around this topic. Experts broadly encourage improving sleep hygiene with easy but key changes including maintaining a consistent schedule, a darker environment during sleeping hours, less screen time prior to sleep, and consistent day-time habits that promote more regular circadian rhythms, including caffeine restriction and exercise. Through these methods, the hope is that societal outcomes for sleep efficacy can improve.

Source: https://www.forbes.com/sites/saibala/2026/01/21/insufficient-sleep-is-a-growing-crisis/

Market Opportunity
Humans.ai Logo
Humans.ai Price(HEART)
$0.001219
$0.001219$0.001219
+2.69%
USD
Humans.ai (HEART) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Stellar (XLM) Price Analysis for February 1

Stellar (XLM) Price Analysis for February 1

The post Stellar (XLM) Price Analysis for February 1 appeared on BitcoinEthereumNews.com. The crypto market keeps reaching new local lows, according to CoinStats
Share
BitcoinEthereumNews2026/02/02 05:21
PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness

PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness

The post PEPE Price Prediction: Meme Coin Targets Recovery Despite Technical Weakness appeared on BitcoinEthereumNews.com. Timothy Morano Feb 01, 2026 16:58
Share
BitcoinEthereumNews2026/02/02 05:00